N. Schoenfeld (Berlin, Germany), V. Ninane (Brussels, Belgium)
4 year lung cancer audit in a Dublin teaching hospital
S. Shahbaz, U. Nic Ionmhain, F. O‘Connell (Dublin, Ireland)
|   |
Nursing personal & respiratory cancer care: field experiences of Indian cancer N.G.O.
D. S. Pramod, P. S. Vaishali (Dhule, India)
| |
Socioeconomic deprivation as a poor prognostic factor in small cell lung cancer (SCLC)
G. Hardavella, E. Nasaina, P. Galanis, E. Arkoumani, Y. Dalavanga, D. Stefanou, S. Constantopoulos, A. Maina (Athens, Ioannina, Strasbourg, Greece)
| |
Prognostic impact of socioeconomic status and health care access in non small cell lung cancer (NSCLC)
G. Hardavella, P. Galanis, E. Nasaina, Y. Dalavanga, D. Stefanou, S. Constantopoulos, A. Maina (Athens, Ioannina, Greece; Strasbourg, France)
| |
How do health care providers, lung cancer patients and their caregivers communicate? An in depth-study
R. M. Schook, R. L. C. Hoek, van, M. Stegenga, C. Linssen, E. Lammers, C. Weenink, P. E. Postmus (Amsterdam, Baarn, Zutphen, Haarlem, Netherlands)
| |
Accounting total direct cost of lung cancer inpatients in Iran, 2005 (in Masih Daneshvari hospital)
H. Zare, M. Azadi (Tehran, Islamic Republic Of Iran)
| |
Fast track lung cancer service in a tertiary care centre
R. A. Mustafa, R. Mogal, P. K. Plant, M. E. J. Callister (Leeds, United Kingdom)
| |
Case-mix adjusted outcomes in the national lung cancer audit in England
P. Beckett, I. Woolhouse, R. Stanley, M. Peake (London, Leeds, United Kingdom)
| |
Deprivation and referrals to a rapid access lung cancer service
J. Greenwood, A. Ponnuswamy, V. Sreeguru Lakshman, M. Ledson, M. Walshaw (Liverpool, United Kingdom)
| |
A considerable reduction of the diagnostic delay from 2000 to 2008 has at most contributed to a modest improvement of survival in Danish lung cancer patients
N. C. Hansen, H. Dall Madsen (Odense, Denmark)
| |
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting?
A. Rich, L. Tata, C. Free, M. Peake, P. Beckett, R. Stanley, D. Baldwin, R. Hubbard (Nottingham, Leicester, Burton-on-Trent, Leeds, United Kingdom)
| |
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
J. P. De Torres, J. P. Wisnivesky, G. Bastarrica, L. Seijo, A. B. Alcaide, A. Campo, A. Villanueva, J. Pueyo, M. D. Lozano, L. Montuenga, J. J. Zulueta (Pamplona, Spain; New York, United States Of America)
| |
Performance scores in patients with suspected lung cancer: reliability of scoring and impact on treatment
S. Wyn-Jones, K. Whitfield, G. Antunes, S. Murphy (Middlesbrough, United Kingdom)
| |
Biological analysis of the single codon deletion in Exon 19 of EGF receptor in non-small cell lung cancer responsive to gefitinib
H. Nitanai, M. Ogasawara, K. Yamauchi, N. Sasaki, Y. Utsumi, N. Suzuki, S. Akiyama, H. Nagashima, Y. Nakamura, H. Kobayashi, H. Inoue (Morioka, Toon, Japan)
| |
Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC)
V. S. Sreeguru Lakshman, K. Mohan, H. Burhan, A. Ponnuswamy, J. Greenwood, M. Ledson, M. Walshaw (Liverpool, United Kingdom)
| |
Study to assess the utility of head CT in the staging of lung cancer in the post-PET era
L. Jones, L. Burke, P. Plant (Leeds, United Kingdom)
| |